Lv01
0 积分 2024-10-31 加入
Abstract 5541: BGB-15025, a potent and selective HPK1 inhibitor, is efficacious as a single agent or in combination with PD-1 antibody in multiple tumor models
2小时前
求助中
Abstract 5541: BGB-15025, a potent and selective HPK1 inhibitor, is efficacious as a single agent or in combination with PD-1 antibody in multiple tumor models
21天前
已完结
Inhibitors of immuno-oncology target HPK1 – a patent review (2016 to 2020)
23天前
已完结
Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based Immunotherapies
23天前
已完结
Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation
26天前
已完结
皖公网安备34019202002308
